Interpretation of quality-of-life scores.
Patients' reports of their experience with illness are a key health outcome, but scores that measure these reports can be difficult to interpret. Skindex-29 measures skin-related quality of life reliably and validly. In this issue, Prinsen and colleagues compare patients' responses to "anchor" questions with their Skindex scores to derive clinically meaningful scores for the subscales of Skindex-29. The cutoff scores identify patients whose skin diseases severely affect their quality of life.
Chren
Mary-Margaret
MM
Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. chrenm@derm.ucsf.edu
D006304:Health Status; D006801:Humans; D011594:Psychometrics / Q000379:methods* / Q000592:standards; D011788:Quality of Life; D012871:Skin Diseases / Q000503:physiopathology* / Q000523:psychology*
J Invest Dermatol. 2007 Dec;127(12):2726-39
17989733
BMJ. 2001 Jul 21;323(7305):157-62
11463691
BMJ. 2009 Jan 12;338:a3006
19139138
N Engl J Med. 1992 Oct 22;327(17):1185-91
1383816
Biom J. 2005 Aug;47(4):458-72
16161804
J Invest Dermatol. 2010 May;130(5):1318-22
20032989
Med Care. 1995 Apr;33(4 Suppl):AS286-91
7723457
J Urol. 1993 Sep;150(3):887-92
7688433
J Invest Dermatol. 2010 Jan;130(1):1-2
20010855
Dermatology. 2009;218(2):151-4
19060458
J Invest Dermatol. 2005 Oct;125(4):viii-ix
16185256
Qual Life Res. 1993 Jun;2(3):221-6
8401458